DK56389D0 - Forhindring og behandling af retroviralt frembragte sygdomme - Google Patents

Forhindring og behandling af retroviralt frembragte sygdomme

Info

Publication number
DK56389D0
DK56389D0 DK056389A DK56389A DK56389D0 DK 56389 D0 DK56389 D0 DK 56389D0 DK 056389 A DK056389 A DK 056389A DK 56389 A DK56389 A DK 56389A DK 56389 D0 DK56389 D0 DK 56389D0
Authority
DK
Denmark
Prior art keywords
immunogen
retrovirus
hiv
infectious
useful
Prior art date
Application number
DK056389A
Other languages
Danish (da)
English (en)
Other versions
DK56389A (da
Inventor
Jonas Salk
Dennis J Carlo
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Publication of DK56389A publication Critical patent/DK56389A/da
Publication of DK56389D0 publication Critical patent/DK56389D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DK056389A 1987-06-10 1989-02-08 Forhindring og behandling af retroviralt frembragte sygdomme DK56389D0 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6028087A 1987-06-10 1987-06-10
US20075288A 1988-05-31 1988-05-31
PCT/US1988/001955 WO1988009670A1 (en) 1987-06-10 1988-06-09 Prevention and treatment of retroviral disease

Publications (2)

Publication Number Publication Date
DK56389A DK56389A (da) 1989-02-08
DK56389D0 true DK56389D0 (da) 1989-02-08

Family

ID=26739775

Family Applications (1)

Application Number Title Priority Date Filing Date
DK056389A DK56389D0 (da) 1987-06-10 1989-02-08 Forhindring og behandling af retroviralt frembragte sygdomme

Country Status (14)

Country Link
EP (3) EP0602761A1 (sv)
JP (1) JPH0720880B2 (sv)
AT (1) ATE132374T1 (sv)
AU (1) AU612383B2 (sv)
CA (1) CA1336407C (sv)
DE (1) DE3854857T2 (sv)
DK (1) DK56389D0 (sv)
FI (1) FI95871C (sv)
IL (1) IL86675A (sv)
NO (1) NO175846C (sv)
OA (1) OA09037A (sv)
RU (1) RU2111010C1 (sv)
UA (1) UA27716C2 (sv)
WO (1) WO1988009670A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620804B2 (en) * 1987-03-23 1992-02-27 Hiver Limited Novel vaccines
US5256767A (en) * 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5227159A (en) * 1989-01-31 1993-07-13 Miller Richard A Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
EP0474868B1 (en) * 1989-05-30 1996-11-13 Nippon Zeon Co., Ltd. Method of producing core structure of retro virus and particle produced thereby
FR2661834B1 (fr) * 1990-05-09 1995-01-27 Merieux Inst Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus.
WO1994002171A1 (en) * 1992-07-20 1994-02-03 The Immune Response Corporation Prophylactic and therapeutic control of retroviral infections
DE69515028T2 (de) * 1994-03-22 2000-06-29 The Immune Response Corp., Carlsbad Die hocheffiziente herstellung und isolierung von viruspartikeln
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
DK507185A (da) * 1984-11-05 1986-05-06 Du Pont Fremgangsmaade til inaktivering af human tumor leukaemi virus iii
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
ATE138100T1 (de) * 1984-12-24 1996-06-15 Genentech Inc Fusionen von aids-verwandten polypeptiden
GR860915B (en) * 1985-04-08 1986-07-11 Genetic Systems Corp Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
WO1987002892A1 (en) * 1985-11-14 1987-05-21 President And Fellows Of Harvard College T-lymphotrophic virus
EP0250128A3 (en) * 1986-06-18 1988-06-08 American Registry of Pathology Novel virus isolated from patients with aids
WO1988007058A1 (en) * 1987-03-16 1988-09-22 Biosolutions Pty. Ltd. Anti-paratopic antibody as an immunogen

Also Published As

Publication number Publication date
DE3854857D1 (de) 1996-02-15
DK56389A (da) 1989-02-08
EP0685236A1 (en) 1995-12-06
EP0317622A4 (en) 1990-05-14
ATE132374T1 (de) 1996-01-15
FI95871B (sv) 1995-12-29
AU1962688A (en) 1989-01-04
CA1336407C (en) 1995-07-25
RU2111010C1 (ru) 1998-05-20
EP0317622A1 (en) 1989-05-31
FI95871C (sv) 1996-04-10
JPH0720880B2 (ja) 1995-03-08
NO175846B (sv) 1994-09-12
WO1988009670A1 (en) 1988-12-15
EP0602761A1 (en) 1994-06-22
OA09037A (en) 1991-03-31
DE3854857T2 (de) 1996-08-22
NO890565D0 (no) 1989-02-09
NO175846C (no) 1994-12-21
FI890603A0 (sv) 1989-02-08
EP0317622B1 (en) 1996-01-03
FI890603A (sv) 1989-02-08
NO890565L (no) 1989-02-09
UA27716C2 (uk) 2000-10-16
AU612383B2 (en) 1991-07-11
JPH02500440A (ja) 1990-02-15
IL86675A (en) 1993-04-04

Similar Documents

Publication Publication Date Title
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
DK1276896T3 (da) Epitop-synkronisering i antigen-præsenterende celler
ATE331026T1 (de) Antigen-markierte nicht-infektiöse retrovirus- ähnlige partikel
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
EP0330359A3 (en) Composition useful in the diagnosis and treating of hiv-1 infection
ATE418562T1 (de) Ctl epitope des epstein-barr virus
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
HUP9801560A1 (hu) Szaponint és szterint tartalmazó vakcinák
CY1111636T1 (el) Εμβολιο που περιεχει gp120 και nef kai/´h tat για ανοσοποιηση εναντι hiv
DK56389A (da) Forhindring og behandling af retroviralt frembragte sygdomme
ATE188484T1 (de) Immunologisch mit hla homologe hiv protein epitope
IE881282L (en) Monoclonal antibodies to specific antigenic regions of the¹human immunodeficiency virus and methods for use.
DE3853672D1 (de) Nichtzurückschlagende RNS-Viren.
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
DE69707680D1 (de) Caprin arthritis-enzephalitis virus enthaltende vakzine und verwendung zur immunschutz gegen hiv-1 infektion
ATE284709T1 (de) Virale chimären aus caev und hiv-1 genetischen elementen
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
ITRM950209A1 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
IT1233419B (it) Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
EA199700353A1 (ru) Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции
EP0309898A3 (en) Method for the induction of a cytotoxic t cell response

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment